Evaluation of urinary speciated arsenic in NHANES: Issues in interpretation in the context of potential inorganic arsenic exposure

Regulatory Toxicology and Pharmacology

Volumn 69, Issue 1, 2014, Pages 49-54

  Aylward, Lesa L ^a   Ramasamy, Santhini ^b   Hays, Sean M ^a   Schoeny, Rita ^b   Kirman, Christopher R ^a  

^a LLP   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Arsenic; Biomonitoring; Exposure assessment; NHANES

Indexed keywords

ARSENIC; ARSENIC ACID; ARSENIC TRIOXIDE; ARSENOBETAINE; ARSENOCHOLINE; CACODYLIC ACID; FOLIC ACID; METHANEARSONIC ACID; TRIMETHYLARSINE OXIDE; BIOLOGICAL MARKER; ORGANOARSENIC DERIVATIVE; WATER POLLUTANT;

AGE; ARTICLE; BIOLOGICAL MONITORING; BODY MASS; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; EXPOSURE; FOLIC ACID BLOOD LEVEL; HUMAN; LIMIT OF DETECTION; PRIORITY JOURNAL; RENAL SYSTEM PARAMETERS; SECONDARY METHYLATION INDEX; SEX; SMOKING; URINALYSIS; URINE LEVEL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; NUTRITION; PROCEDURES; SEA FOOD; URINE; WATER POLLUTANT;

ARSENIC; ARSENICALS; BIOLOGICAL MARKERS; CACODYLIC ACID; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HUMANS; NUTRITION SURVEYS; SEAFOOD; WATER POLLUTANTS, CHEMICAL;

EID: 84896540984     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2014.02.011     Document Type: Article

References (43)

1. Adair B.M., et al. Commonalities in metabolism of arsenicals. Environ. Chem. 2005, 2:161-166.
2. Ahsan H., et al. Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1270-1278.
3. Aylward L.L., et al. Evaluation of biomonitoring data from the CDC national exposure report in a risk assessment context: perspectives across chemicals. Environ. Health Perspect. 2013, 121:287-294.
4. Barr D.B., et al. Urinary creatinine concentrations in the US population: implications for urinary biologic monitoring measurements. Environ. Health Perspect. 2005, 113:192-200.
5. Basu A., et al. Creatinine, diet, micronutrients, and arsenic methylation in West Bengal, India. Environ. Health Perspect. 2011, 119:1308-1313.
6. Borak J., Hosgood H.D. Seafood arsenic: implications for human risk assessment. Regul. Toxicol. Pharmacol. 2007, 47:204-212.
7. Buchet J.P., Lauwerys R., Roels H. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int. Arch. Occup. Environ. Health 1981, 48:71-79.
8. Centers for Disease Control and Prevention (CDC), 2012. National health and nutrition examination survey (NHANES), questionnaires, datasets, and documentation. Available at: <> (accessed: 28 January 2013). http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm.
9. Chen Y.C., et al. Arsenic methylation and skin cancer risk in southwestern Taiwan. J. Occup. Environ. Med. 2003, 45:241-248.
10. Chen Y.C., et al. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer. Cancer Causes Control 2005, 16:75-81.
11. Chowdhury U.K., et al. Pattern of excretion of arsenic compounds [arsenite, arsenate, MMA(V), DMA(V)] in urine of children compared to adults from an arsenic exposed area in Bangladesh. J. Environ. Sci. Health A 2003, 38:87-113.
12. Cohen S.M. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit. Rev. Toxicol. 2006, 36:99-133.
13. Devesa V., et al. Organoarsenical species contents in cooked seafood. J. Agric. Food Chem. 2005, 53:8813-8819.
14. Gamble M.V., et al. Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am. J. Clin. Nutr. 2006, 84:1093-1101.
15. Gamble M.V., et al. Folic acid supplementation lowers blood arsenic. Am. J. Clin. Nutr. 2007, 86:1202-1209.
16. Gao J., Yu J., Yang L. Urinary arsenic metabolites of subjects exposed to elevated arsenic present in coal in Shaanxi Province, China. Int. J. Environ. Res. Public Health 2011, 8:1991-2008.
17. Hata A., et al. Arsenic speciation analysis of urine samples from individuals living in an arsenic-contaminated area in Bangladesh. Environ. Health Prev. Med. 2012, 17:235-245.
18. Hays S.M., et al. Guidelines for the derivation of biomonitoring equivalents: report from the biomonitoring equivalents expert workshop. Reg. Toxicol. Pharmacol. 2008, 51:S4-S15.
19. Hays S.M., et al. Biomonitoring equivalents for inorganic arsenic. Reg. Toxicol. Pharmacol. 2010, 58:1-9.
20. Health Canada, 2008. Pest Management Regulatory Agency (PMRA). EPA/PMRA Joint Review of Chromated Copper Arsenate (CCA) Registration Re-evaluation, Available by request from Health Canada PMRA. <>. http://www.hc-sc.gc.ca/cps-spc/pest/index-eng.php.
21. Hsueh Y.M., et al. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol. Biomarkers Prev. 1997, 6:589-596.
22. Hsueh Y.M., et al. Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J. Toxicol. Environ. Health A 1998, 54:431-444.
23. Huang Y.K., et al. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. Toxicol. Appl. Pharmacol. 2007, 218:135-142.
24. Kenyon E.M., et al. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water. Toxicol. Appl. Pharmacol. 2008, 232:448-455.
25. Lindberg A.L., et al. Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms. Environ. Health Perspect. 2007, 115:1081-1086.
26. Lindberg A.-L., et al. Gender and age differences in the metabolism of inorganic arsenic in a highly exposed population in Bangladesh. Environ. Res. 2008, 106:110-120.
27. Mohri T., Hisanaga A., Ishinishi N. Arsenic intake and excretion by Japanese adults: a 7-day duplicate diet study. Food Chem. Toxicol. 1990, 28:521-529.
28. Molin M., et al. Humans seem to produce arsenobetaine and dimethylarsinate after a bolus dose of seafood. Environ. Res. 2012, 112:28-39.
29. National Research Council (NRC) 2001. Arsenic in Drinking Water: 2001 Update Subcommittee to Update the 1999 Arsenic in Drinking Water Report, Committee on Toxicology, Board on Environmental Studies and Toxicology, National Research Council. National Academies Press, Washington, DC.
30. National Research Council (NRC) Critical Aspects of EPA's IRIS Assessment of Inorganic Arsenic: Interim Report 2013, The National Academies Press, Washington, DC.
31. Navas-Acien A., et al. Seafood intake and urine concentrations of total arsenic, dimethylarsinate and arsenobetaine in the US population. Environ. Res. 2011, 111:110-118.
32. Schoof R., Yager J.W. Variation of total and speciated arsenic in commonly consumed fish and seafood. Human Ecol. Risk Assess. 2007, 13:946-965.
33. Schuhmacher-Wolz U., et al. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects. Crit. Rev. Toxicol. 2009, 39:271-298.
34. Sun G., et al. Urinary arsenic metabolites in children and adults exposed to arsenic in drinking water in Inner Mongolia, China. Environ. Health Perspect. 2007, 115:648-652.
35. Tseng C.H. Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2007, 25:1-22.
36. Tseng C.H. A review on environmental factors regulating arsenic methylation in humans. Toxicol. Appl. Pharmacol. 2009, 235:338-350.
37. USEPA National primary drinking water regulation; arsenic and clarifications to compliance and new source contaminants monitoring; final rule. Fed. Regist. 2001, 66:6975.
38. USEPA, 2005. Science issue paper: mode of carcinogenic action for cacodylic acid (dimethylarsinic acid, DMAV) and recommendations for dose response extrapolation July 26, 2005. Health Effects Division, Office of Pesticide Programs, Washington, DC, USA. Available at: <>. http://www.epa.gov/sab/panels/arsenic%20review%20panel.htm.
39. USEPA, 2006. Revised reregistration eligibility decision for MSMA, DSMA, CAMA, and cacodylic acid. EPA 738-R-06-021. Office of Prevention, Pesticides, and Toxic Substances, Washington, DC. Available: <> (Accessed 27 January 2012). http://www.epa.gov/oppsrrd1/REDs/organic_arsenicals_red.pdf.
40. USEPA, 2008. Reregistration eligibility decision for chromated arsenicals. <> (Accessed 9 September 2013). http://www.epa.gov/oppsrrd1/REDs/cca_red.pdf.
41. USEPA, 2010. IRIS toxicological review of inorganic arsenic (cancer) (external review draft). <> (Accessed 27 December 2013). http://yosemite.epa.gov/sab/sabproduct.nsf/02ad90b136fc21ef85256eba00436459/6f904bdb47d141d9852576b90078c987!OpenDocument.
42. USEPA Science Advisory Board, 2011. Review of EPA's responsiveness to SAB 2007 recommendations for the revision of cancer assessment of inorganic arsenic - a report of the SAB inorganic arsenic cancer review work group. <> (Accessed 27 December 2013). http://yosemite.epa.gov/sab/sabproduct.nsf/02ad90b136fc21ef85256eba00436459/6f904bdb47d141d9852576b90078c987!OpenDocument%26TableRow=2.3#2.
43. Vahter M. Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog. 1999, 82:69-88.